Artivion, Inc. (NYSE:AORT – Get Free Report) shares fell 6.3% on Tuesday . The company traded as low as $16.19 and last traded at $16.31. 32,127 shares traded hands during mid-day trading, a decline of 80% from the average session volume of 158,639 shares. The stock had previously closed at $17.41. Wall Street Analyst Weigh […]
Artivion (NYSE:AORT – Get Free Report) and Nevro (NYSE:NVRO – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, valuation, analyst recommendations and dividends. Profitability This table compares Artivion and Nevro’s net margins, […]
/PRNewswire/ Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will participate.
Artivion, Inc. (NYSE:AORT – Get Rating) VP Matthew A. Getz sold 6,329 shares of the stock in a transaction on Wednesday, June 7th. The shares were sold at an average price of $15.88, for a total value of $100,504.52. Following the completion of the transaction, the vice president now directly owns 30,387 shares in the […]
Artivion, Inc. (NYSE:AORT – Get Rating) SVP Dennis B. Maier sold 16,254 shares of the company’s stock in a transaction dated Tuesday, June 6th. The shares were sold at an average price of $15.27, for a total transaction of $248,198.58. Following the transaction, the senior vice president now owns 34,724 shares in the company, valued […]